Optimising diagnostic yield in highly penetrant genomic disease
Caroline F. Wright, Patrick Campbell, Ruth Y. Eberhardt, Stuart Aitken, Daniel Perrett, Simon Brent, Petr Danecek, Eugene J. Gardner, V. Kartik Chundru, Sarah J. Lindsay, Katrina Andrews, Juliet Hampstead, Joanna Kaplanis, Kaitlin E. Samocha, Anna Middleton, Julia Foreman, Rachel J. Hobson, Michael J. Parker, Hilary C. Martin, David R. FitzPatrick, Matthew E. Hurles, Helen V. Firth the DDD Study
doi: https://doi.org/10.1101/2022.07.25.22278008
Caroline F. Wright
1Institute of Biomedical and Clinical Science, University of Exeter Medical School, RILD Building, Royal Devon & Exeter Hospital, Barrack Road, Exeter UK, EX2 5DW
PhDPatrick Campbell
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
3Cambridge University Hospitals Foundation Trust, Addenbrooke’s Hospital, Cambridge, CB2 0QQ
MBBSRuth Y. Eberhardt
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDStuart Aitken
4MRC Human Genetics Unit, Institute of Genetic and Cancer, University of Edinburgh, Edinburgh EH4 2XU
PhDDaniel Perrett
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
MPhilSimon Brent
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
BScPetr Danecek
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDEugene J. Gardner
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDV. Kartik Chundru
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDSarah J. Lindsay
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDKatrina Andrews
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
MBBChJuliet Hampstead
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
BScJoanna Kaplanis
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDKaitlin E. Samocha
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDAnna Middleton
5Wellcome Connecting Science, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA
PhDJulia Foreman
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDRachel J. Hobson
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDMichael J. Parker
6Wellcome Centre for Ethics and Humanities/Ethox Centre, Oxford Population Health, University of Oxford, Big Data Institute, Old Road Campus, Oxford, OX3 7LF
PhDHilary C. Martin
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDDavid R. FitzPatrick
4MRC Human Genetics Unit, Institute of Genetic and Cancer, University of Edinburgh, Edinburgh EH4 2XU
DMMatthew E. Hurles
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
PhDHelen V. Firth
2Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA
3Cambridge University Hospitals Foundation Trust, Addenbrooke’s Hospital, Cambridge, CB2 0QQ
DMData Availability
All data produced are available upon request from the European Genome-phenome Archive.
Posted July 25, 2022.
Optimising diagnostic yield in highly penetrant genomic disease
Caroline F. Wright, Patrick Campbell, Ruth Y. Eberhardt, Stuart Aitken, Daniel Perrett, Simon Brent, Petr Danecek, Eugene J. Gardner, V. Kartik Chundru, Sarah J. Lindsay, Katrina Andrews, Juliet Hampstead, Joanna Kaplanis, Kaitlin E. Samocha, Anna Middleton, Julia Foreman, Rachel J. Hobson, Michael J. Parker, Hilary C. Martin, David R. FitzPatrick, Matthew E. Hurles, Helen V. Firth
medRxiv 2022.07.25.22278008; doi: https://doi.org/10.1101/2022.07.25.22278008
Optimising diagnostic yield in highly penetrant genomic disease
Caroline F. Wright, Patrick Campbell, Ruth Y. Eberhardt, Stuart Aitken, Daniel Perrett, Simon Brent, Petr Danecek, Eugene J. Gardner, V. Kartik Chundru, Sarah J. Lindsay, Katrina Andrews, Juliet Hampstead, Joanna Kaplanis, Kaitlin E. Samocha, Anna Middleton, Julia Foreman, Rachel J. Hobson, Michael J. Parker, Hilary C. Martin, David R. FitzPatrick, Matthew E. Hurles, Helen V. Firth
medRxiv 2022.07.25.22278008; doi: https://doi.org/10.1101/2022.07.25.22278008
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12635)
- Forensic Medicine (10)
- Gastroenterology (815)
- Genetic and Genomic Medicine (4498)
- Geriatric Medicine (411)
- Health Economics (719)
- Health Informatics (2877)
- Health Policy (1060)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4266)
- Nursing (228)
- Nutrition (626)
- Oncology (2236)
- Ophthalmology (637)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (490)
- Public and Global Health (6846)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)